<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05120388</url>
  </required_header>
  <id_info>
    <org_study_id>11012021</org_study_id>
    <nct_id>NCT05120388</nct_id>
  </id_info>
  <brief_title>Effect of Extra Virgin Olive Oil Addition in the Diet of Women With Gestational Diabetes Mellitus (OLIDIAG)</brief_title>
  <acronym>OLIDIAG</acronym>
  <official_title>Effect of Extra Virgin Olive Oil Addition in the Diet of Women With Gestational Diabetes Mellitus (OLIDIAG)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Center for Pharmacological and Botanical Research</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Sociedad Argentina de Diabetes</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Center for Pharmacological and Botanical Research</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Gestational diabetes mellitus (GDM) is associated to adverse maternal and neonatal outcomes.&#xD;
      The aim of this study is to address whether the addition of extra virgin olive oil to the&#xD;
      diet of women with GDM improves maternal triglyceridemia and reduces insulin requirement and&#xD;
      diagnosis of diabetes at postnatal reclassification.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study is a randomized trial in which 1200 pregnant women at GDM diagnosis from 16 health&#xD;
      care centers will be recruited and randomized in two parallel arms: 1 World Health&#xD;
      Organization (WHO)-diet supplemented with 3 tablespoons of Extra Virgin Olive Oil&#xD;
      (Intervention Group, n=600); 2. WHO-diet with no Extra Virgin Olive Oil supplementation&#xD;
      (Control Group, n=600). Expected results: the investigators expect that the intervention will&#xD;
      contribute to improve maternal lipid profile, reduce insulin requirement and reduce maternal&#xD;
      diagnosis of diabetes at postpartum reclassification. Thus, this study is expected to&#xD;
      identify maternal beneficial effects of this dietary intervention.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">November 15, 2021</start_date>
  <completion_date type="Anticipated">March 30, 2024</completion_date>
  <primary_completion_date type="Anticipated">November 15, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Dietary intervention study: GDM patients receiving a WHO diet with or without addition of extra virgin olive oil</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Investigator)</masking>
    <masking_description>Data analysis will be masked</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>maternal triglyceridemia</measure>
    <time_frame>term pregnancy</time_frame>
    <description>triglycerides in mg/dl</description>
  </primary_outcome>
  <primary_outcome>
    <measure>maternal weight gain</measure>
    <time_frame>change from prepregnancy weight to term pregnancy weight</time_frame>
    <description>gestational maternal weight gain in kg</description>
  </primary_outcome>
  <primary_outcome>
    <measure>number of participants with insulin requirement</measure>
    <time_frame>term pregnancy</time_frame>
    <description>insulin use</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>number of participants with diabetes at postpartum</measure>
    <time_frame>six weeks postpartum</time_frame>
    <description>maternal diagnosis of diabetes at postpartum</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">1200</enrollment>
  <condition>Gestational Diabetes</condition>
  <arm_group>
    <arm_group_label>Dietary addition of extra virgin olive oil</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>WHO diet with a daily addition of extra virgin olive oil</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No addition of extra virgin Olive Oil</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>WHO diet</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Extra Virgin Olive Oil Addition</intervention_name>
    <description>Daily dietary addition of olive oil (three tablespoons)</description>
    <arm_group_label>Dietary addition of extra virgin olive oil</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  GDM (diagnosis criteria of the Latin American Society of Diabetes (ALAD) and Argentine&#xD;
             Society of Diabetes (SAD): Fasting plasma glucosa &gt; 100 mg/dl, p75 oral glucose&#xD;
             tolerance test-2 h plasma glucose &gt; 140 mg/dl)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Multiple pregnancy&#xD;
&#xD;
          -  Pregestational diabetes (type 1 or type 2)&#xD;
&#xD;
          -  Bariatric surgery&#xD;
&#xD;
          -  Infectious diseases&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>October 14, 2021</study_first_submitted>
  <study_first_submitted_qc>November 3, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">November 15, 2021</study_first_posted>
  <last_update_submitted>November 3, 2021</last_update_submitted>
  <last_update_submitted_qc>November 3, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 15, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>GDM</keyword>
  <keyword>Extra Virgin Olive Oil</keyword>
  <keyword>lipid profile</keyword>
  <keyword>insulin requirement</keyword>
  <keyword>postpartum reclassification</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes, Gestational</mesh_term>
    <mesh_term>Diabetes Mellitus</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

